Apocynin in Diabetes: Modulation of Oxidative Stress and Inflammatory Signaling
Biosciences Biotechnology Research Asia · 26.06.2026 · 2 (23) · 546
DOI: 10.13005/bbra/3517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosciences Biotechnology Research Asia, online erschienen am 25.06.2026. Verfasst von Ubaidur Rahman Khan und 2 weiteren Autor:innen. Die Arbeit nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia and progressive development of microvascular and macrovascular complications. Increasing evidence identifies oxidative stress and redox-sensitive inflammatory signaling as central mechanisms underlying diabetes-associated organ injury. Apocynin, a naturally occurring methoxy-substituted phenolic compound, has gained attention as a redox-modulating agent with potential therapeutic relevance in diabetes. The present review summarizes the chemical characteristics, mechanistic actions, and protective effects of apocynin in experimental models of diabetic complications. Apocynin primarily acts through inhibition of NADPH oxidase assembly, thereby limiting excessive reactive oxygen species generation and suppressing downstream activation of redox-sensitive pathways. Through modulation of oxidative and inflammatory cascades, apocynin demonstrates protective effects in diabetic nephropathy, neuropathy, cardiomyopathy, and retinopathy. In addition to reducing oxidative burden, apocynin supports endogenous antioxidant defenses and improves cellular and metabolic stability. However, despite these promising findings, no clinical studies have yet evaluated apocynin in patients with diabetes or its associated complications. Although preclinical findings are promising, translational challenges, including pharmacokinetic limitations and limited clinical evaluation, remain to be addressed. Collectively, apocynin emerges as a promising candidate targeting convergent redox-inflammatory pathways implicated in diabetic complications.
Zitieren
APA
Khan, U. R., Otari, K., & Kale, A. (2026). Apocynin in Diabetes: Modulation of Oxidative Stress and Inflammatory Signaling. Biosciences Biotechnology Research Asia, 2(23), 546. https://doi.org/10.13005/bbra/3517
Vancouver
Khan UR, Otari K, Kale A. Apocynin in Diabetes: Modulation of Oxidative Stress and Inflammatory Signaling. Biosciences Biotechnology Research Asia. 2026;2(23):546. doi:10.13005/bbra/3517
BibTeX
@article{Khan2026,
author = {Khan, Ubaidur Rahman and Otari, Kishor and Kale, Ajay},
title = {Apocynin in Diabetes: Modulation of Oxidative Stress and Inflammatory Signaling},
journal = {Biosciences Biotechnology Research Asia},
year = {2026},
volume = {2},
number = {23},
pages = {546},
doi = {10.13005/bbra/3517}
}
EUVIMED